A new motif for inhibitors of geranylgeranyl diphosphate synthase

Benjamin J. Foust, Cheryl Allen, Sarah A Holstein, David F. Wiemer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The enzyme geranylgeranyl diphosphate synthase (GGDPS) is believed to receive the substrate farnesyl diphosphate through one lipophilic channel and release the product geranylgeranyl diphosphate through another. Bisphosphonates with two isoprenoid chains positioned on the α-carbon have proven to be effective inhibitors of this enzyme. Now a new motif has been prepared with one isoprenoid chain on the α-carbon, a second included as a phosphonate ester, and the potential for a third at the α-carbon. The pivaloyloxymethyl prodrugs of several compounds based on this motif have been prepared and the resulting compounds have been tested for their ability to disrupt protein geranylgeranylation and induce cytotoxicity in myeloma cells. The initial biological studies reveal activity consistent with GGDPS inhibition, and demonstrate a structure–function relationship which is dependent on the nature of the alkyl group at the α-carbon.

Original languageEnglish (US)
Pages (from-to)3734-3741
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume24
Issue number16
DOIs
StatePublished - 2016
Externally publishedYes

Fingerprint

Farnesyltranstransferase
Carbon
Terpenes
Protein Prenylation
Organophosphonates
Prodrugs
Diphosphonates
Enzyme Inhibitors
Cytotoxicity
Esters
Substrates
Enzymes
Proteins

Keywords

  • Bisphosphonate monoester
  • GGDP synthase
  • Inhibition
  • Isoprenoid biosynthesis
  • Prodrug

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

A new motif for inhibitors of geranylgeranyl diphosphate synthase. / Foust, Benjamin J.; Allen, Cheryl; Holstein, Sarah A; Wiemer, David F.

In: Bioorganic and Medicinal Chemistry, Vol. 24, No. 16, 2016, p. 3734-3741.

Research output: Contribution to journalArticle

Foust, Benjamin J. ; Allen, Cheryl ; Holstein, Sarah A ; Wiemer, David F. / A new motif for inhibitors of geranylgeranyl diphosphate synthase. In: Bioorganic and Medicinal Chemistry. 2016 ; Vol. 24, No. 16. pp. 3734-3741.
@article{f8e4fc54c19946cea707f30e23161150,
title = "A new motif for inhibitors of geranylgeranyl diphosphate synthase",
abstract = "The enzyme geranylgeranyl diphosphate synthase (GGDPS) is believed to receive the substrate farnesyl diphosphate through one lipophilic channel and release the product geranylgeranyl diphosphate through another. Bisphosphonates with two isoprenoid chains positioned on the α-carbon have proven to be effective inhibitors of this enzyme. Now a new motif has been prepared with one isoprenoid chain on the α-carbon, a second included as a phosphonate ester, and the potential for a third at the α-carbon. The pivaloyloxymethyl prodrugs of several compounds based on this motif have been prepared and the resulting compounds have been tested for their ability to disrupt protein geranylgeranylation and induce cytotoxicity in myeloma cells. The initial biological studies reveal activity consistent with GGDPS inhibition, and demonstrate a structure–function relationship which is dependent on the nature of the alkyl group at the α-carbon.",
keywords = "Bisphosphonate monoester, GGDP synthase, Inhibition, Isoprenoid biosynthesis, Prodrug",
author = "Foust, {Benjamin J.} and Cheryl Allen and Holstein, {Sarah A} and Wiemer, {David F.}",
year = "2016",
doi = "10.1016/j.bmc.2016.06.019",
language = "English (US)",
volume = "24",
pages = "3734--3741",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "16",

}

TY - JOUR

T1 - A new motif for inhibitors of geranylgeranyl diphosphate synthase

AU - Foust, Benjamin J.

AU - Allen, Cheryl

AU - Holstein, Sarah A

AU - Wiemer, David F.

PY - 2016

Y1 - 2016

N2 - The enzyme geranylgeranyl diphosphate synthase (GGDPS) is believed to receive the substrate farnesyl diphosphate through one lipophilic channel and release the product geranylgeranyl diphosphate through another. Bisphosphonates with two isoprenoid chains positioned on the α-carbon have proven to be effective inhibitors of this enzyme. Now a new motif has been prepared with one isoprenoid chain on the α-carbon, a second included as a phosphonate ester, and the potential for a third at the α-carbon. The pivaloyloxymethyl prodrugs of several compounds based on this motif have been prepared and the resulting compounds have been tested for their ability to disrupt protein geranylgeranylation and induce cytotoxicity in myeloma cells. The initial biological studies reveal activity consistent with GGDPS inhibition, and demonstrate a structure–function relationship which is dependent on the nature of the alkyl group at the α-carbon.

AB - The enzyme geranylgeranyl diphosphate synthase (GGDPS) is believed to receive the substrate farnesyl diphosphate through one lipophilic channel and release the product geranylgeranyl diphosphate through another. Bisphosphonates with two isoprenoid chains positioned on the α-carbon have proven to be effective inhibitors of this enzyme. Now a new motif has been prepared with one isoprenoid chain on the α-carbon, a second included as a phosphonate ester, and the potential for a third at the α-carbon. The pivaloyloxymethyl prodrugs of several compounds based on this motif have been prepared and the resulting compounds have been tested for their ability to disrupt protein geranylgeranylation and induce cytotoxicity in myeloma cells. The initial biological studies reveal activity consistent with GGDPS inhibition, and demonstrate a structure–function relationship which is dependent on the nature of the alkyl group at the α-carbon.

KW - Bisphosphonate monoester

KW - GGDP synthase

KW - Inhibition

KW - Isoprenoid biosynthesis

KW - Prodrug

UR - http://www.scopus.com/inward/record.url?scp=84978196680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978196680&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2016.06.019

DO - 10.1016/j.bmc.2016.06.019

M3 - Article

VL - 24

SP - 3734

EP - 3741

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 16

ER -